Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Ochsner J ; 22(1): 22-25, 2022.
Article in English | MEDLINE | ID: covidwho-1772165

ABSTRACT

Background: The United States of America is the leading country in confirmed cases of and deaths from severe acute respiratory syndrome coronavirus 2, the virus that causes coronavirus disease 2019 (COVID-19). In April and May 2020, respectively, 0.2% of patients in a Chinese COVID-19-positive cohort and 20.4% of patients in an Italian COVID-19-positive cohort developed cutaneous abnormalities. Cutaneous abnormalities associated with COVID-19 are not well documented or discussed, and investigation of cutaneous manifestations is necessary to determine if they have any clinical value. Methods: We conducted a retrospective study of COVID-19-positive patients who were admitted to Ochsner-Louisiana State University-Shreveport and Ochsner-Louisiana State University-Monroe facilities in Louisiana. Cutaneous manifestations were determined from clinical notes, descriptions in medical records, and a billing code for skin rashes. Results: Of 1,086 COVID-19-positive patients investigated, 871 were African American and 130 were Caucasian. Only 10 patents exhibited probable COVID-19-induced cutaneous abnormalities: 6 (0.7%) of the 871 African American patients and 4 (3.1%) of the 130 Caucasian patients. Dermatologic abnormalities included pruritic or erythematous rash and hypopigmentation of the face, upper chest, abdomen, and trunk areas. Our data are consistent with the smaller percentage of patients in the Chinese cohort study vs the larger percentage in the Italian cohort study. Conclusion: Our data provide evidence that cutaneous manifestations of COVID-19, especially in African American patients, are rare, but documentation of more cases is necessary to establish a cause and effect for COVID-19-induced skin manifestations.

2.
OTO Open ; 5(3): 2473974X211047794, 2021.
Article in English | MEDLINE | ID: covidwho-1448101

ABSTRACT

OBJECTIVE: To evaluate the concerns and needs of patients and survivors of head and neck cancer (HNC) in the COVID-19 era. STUDY DESIGN: Prospective cross-sectional survey. SETTING: Contact lists of 5 North American HNC advocacy groups. METHODS: A 14-question survey was distributed to the contact lists of 5 HNC advocacy groups evaluating patient and survivor needs and concerns related to their cancer care and COVID-19. RESULTS: There were 171 respondents, with 75% in the posttreatment period. The most common concern was contraction of COVID-19 (49%). More patients in active treatment preferred in-person visits than those in the early (≤5 years) and late (>5) survivorship period (72% vs 61% vs 40%, P < .001). A higher percentage of late survivors preferred virtual visits (38% vs 28%, P = .001). In total, 91 (53.2%) respondents sought emotional support outside of immediate family and friends. This included cancer support groups (36.2%), the medical team (29.7%), and other sources outside of these (34.1%), including faith-based organizations and online communities. A higher proportion of women than men (62% vs 41%, P = .001) were seeking emotional support outside of immediate family and friends. CONCLUSIONS: During the early stages of the COVID-19 pandemic, patients with HNC who were actively undergoing treatment had increased need for support resources and preferred in-person provider visits. Alternatively, a higher percentage of patients >5 years from treatment preferred virtual visits. Emotional support outside of family and friends was sought out by a majority of respondents. Further research is needed to determine what support and educational resources are needed to best aid these various populations.

3.
Acad Med ; 96(11): 1518-1523, 2021 11 01.
Article in English | MEDLINE | ID: covidwho-1207326

ABSTRACT

Public health crises palpably demonstrate how social determinants of health have led to disparate health outcomes. The staggering mortality rates among African Americans, Native Americans, and Latinx Americans during the COVID-19 pandemic have revealed how recalcitrant structural inequities can exacerbate disparities and render not just individuals but whole communities acutely vulnerable. While medical curricula that educate students about disparities are vital in rousing awareness, it is experience that is most likely to instill passion for change. The authors first consider the roots of health care disparities in relation to the current pandemic. Then, they examine the importance of salient learning experiences that may inspire a commitment to championing social justice. Experiences in diverse communities can imbue medical students with a desire for lifelong learning and advocacy. The authors introduce a 3-pillar framework that consists of trust building, structural competency, and cultural humility. They discuss how these pillars should underpin educational efforts to improve social determinants of health. Effecting systemic change requires passion and resolve; therefore, perseverance in such efforts is predicated on learners caring about the structural inequities in housing, education, economic stability, and neighborhoods-all of which influence the health of individuals and communities.


Subject(s)
COVID-19/psychology , Education, Medical/ethics , Ethnicity/statistics & numerical data , Racism/ethnology , Black or African American , Awareness , COVID-19/diagnosis , COVID-19/epidemiology , COVID-19/virology , Education, Medical/statistics & numerical data , Female , Healthcare Disparities/ethnology , Humans , Male , Minority Groups , Problem-Based Learning/statistics & numerical data , Public Health/ethics , Public Health/statistics & numerical data , SARS-CoV-2/genetics , Social Determinants of Health/ethnology , Social Determinants of Health/statistics & numerical data , Social Justice/ethics , Stakeholder Participation , Students, Medical/statistics & numerical data , United States/epidemiology
5.
Head Neck ; 43(2): 733-738, 2021 02.
Article in English | MEDLINE | ID: covidwho-932433

ABSTRACT

This article provides best practice guidelines regarding nasopharyngolaryngoscopy and OHNS clinic reopening during the COVID-19 pandemic. The aim is to provide evidence-based recommendations defining the risks of COVID-19 in clinic, the importance of pre-visit screening in addition to testing, along with ways to adhere to CDC guidelines for environmental, source, and engineering controls.


Subject(s)
COVID-19/prevention & control , Disease Transmission, Infectious/prevention & control , Otolaryngology/standards , COVID-19/diagnosis , COVID-19/transmission , COVID-19 Testing/standards , Endocrinology/standards , Humans , Mass Screening/standards , Nasal Surgical Procedures/standards , Personal Protective Equipment , Risk , SARS-CoV-2
6.
Head Neck ; 42(7): 1555-1559, 2020 Jul.
Article in English | MEDLINE | ID: covidwho-607685

ABSTRACT

The COVID-19 pandemic has profoundly disrupted head and neck cancer (HNC) care delivery in ways that will likely persist long term. As we scan the horizon, this crisis has the potential to amplify preexisting racial/ethnic disparities for patients with HNC. Potential drivers of disparate HNC survival resulting from the pandemic include (a) differential access to telemedicine, timely diagnosis, and treatment; (b) implicit bias in initiatives to triage, prioritize, and schedule HNC-directed therapy; and (c) the marked changes in employment, health insurance, and dependent care. We present four strategies to mitigate these disparities: (a) collect detailed data on access to care by race/ethnicity, income, education, and community; (b) raise awareness of HNC disparities; (c) engage stakeholders in developing culturally appropriate solutions; and (d) ensure that surgical prioritization protocols minimize risk of racial/ethnic bias. Collectively, these measures address social determinants of health and the moral imperative to provide equitable, high-quality HNC care.


Subject(s)
Betacoronavirus , Coronavirus Infections/epidemiology , Head and Neck Neoplasms/therapy , Health Services Accessibility , Healthcare Disparities , Pneumonia, Viral/epidemiology , COVID-19 , Data Collection , Head and Neck Neoplasms/epidemiology , Health Priorities , Humans , Insurance Coverage , Insurance, Health , Pandemics , Race Factors , Risk Assessment , SARS-CoV-2 , Telemedicine , Triage , Unemployment , United States/epidemiology
7.
Head Neck ; 42(7): 1526-1532, 2020 Jul.
Article in English | MEDLINE | ID: covidwho-434497

ABSTRACT

The COVID-19 pandemic has had a significant impact on many aspects of head and neck cancer (HNC) care. The uncertainty and stress resulting from these changes has led many patients and caregivers to turn to HNC advocacy groups for guidance and support. Here we outline some of the issues being faced by patients with HNC during the current crisis and provide examples of programs being developed by advocacy groups to address them. We also highlight the increased utilization of these organizations that has been observed as well as some of the challenges being faced by these not-for-profit groups as they work to serve the head and neck community.


Subject(s)
Betacoronavirus , Coronavirus Infections/epidemiology , Foundations , Head and Neck Neoplasms , Organizations, Nonprofit , Pneumonia, Viral/epidemiology , COVID-19 , Congresses as Topic , Humans , Pandemics , Patient Advocacy , Patient Education as Topic , SARS-CoV-2 , Social Media , Telemedicine
9.
JAMA Otolaryngol Head Neck Surg ; 146(6): 579-584, 2020 06 01.
Article in English | MEDLINE | ID: covidwho-20526

ABSTRACT

Importance: The rapidly expanding novel coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2, has challenged the medical community to an unprecedented degree. Physicians and health care workers are at added risk of exposure and infection during the course of patient care. Because of the rapid spread of this disease through respiratory droplets, health care workers who come in close contact with the upper aerodigestive tract during diagnostic and therapeutic procedures, such as otolaryngologists-head and neck surgeons, are particularly at risk. A set of safety recommendations was created based on a review of the literature and communications with physicians with firsthand knowledge of safety procedures during the COVID-19 pandemic. Observations: A high number of health care workers were infected during the first phase of the pandemic in the city of Wuhan, China. Subsequently, by adopting strict safety precautions, other regions were able to achieve high levels of safety for health care workers without jeopardizing the care of patients. The most common procedures related to the examination and treatment of upper aerodigestive tract diseases were reviewed. Each category was reviewed based on the potential risk imposed to health care workers. Specific recommendations were made based on the literature, when available, or consensus best practices. Specific safety recommendations were made for performing tracheostomy in patients with COVID-19. Conclusions and Relevance: Preserving a highly skilled health care workforce is a top priority for any community and health care system. Based on the experience of health care systems in Asia and Europe, by following strict safety guidelines, the risk of exposure and infection of health care workers could be greatly reduced while providing high levels of care. The provided recommendations, which may evolve over time, could be used as broad guidance for all health care workers who are involved in the care of patients with COVID-19.


Subject(s)
Betacoronavirus , Consensus , Coronavirus Infections/epidemiology , Otolaryngology/standards , Otorhinolaryngologic Diseases/surgery , Otorhinolaryngologic Surgical Procedures/standards , Patient Care/standards , Pneumonia, Viral/epidemiology , COVID-19 , Comorbidity , Coronavirus Infections/transmission , Disease Transmission, Infectious/prevention & control , Humans , Otorhinolaryngologic Diseases/epidemiology , Pandemics , Pneumonia, Viral/transmission , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL